0000950123-18-002251.txt : 20180214
0000950123-18-002251.hdr.sgml : 20180214
20180214134100
ACCESSION NUMBER: 0000950123-18-002251
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20171231
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
EFFECTIVENESS DATE: 20180214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17790
FILM NUMBER: 18610520
BUSINESS ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
BUSINESS PHONE: 352 24840131
MAIL ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001598762
XXXXXXXX
12-31-2017
12-31-2017
Pharmstandard International S.A.
10a, rue Henri Schnadt
Luxembourg
N4
L-2530
13F HOLDINGS REPORT
028-17790
N
Eriks Martinovskis
Director
352 24840131
/s/ Eriks Martinovskis
Luxembourg
N4
02-13-2018
1
6
97266
false
1
Joint Stock Co Pharmstandard
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Argos Therapeutics Inc.
Common
040221103
39428
13142784
SH
DFND
1
0
13142784
0
Argos Therapeutics Inc.
Common
040221103
15362
5120604
SH
Call
DFND
1
0
5120604
0
Proteon Therapeutics Inc.
Common
74371L109
3169
1667907
SH
DFND
1
0
1667907
0
Protagonist Therapeutics, Inc.
Common
74366E102
20431
982270
SH
DFND
1
0
982270
0
Jounce Therapeutics, Inc.
Common
481116101
8441
662063
SH
DFND
1
0
662063
0
Allena Pharmaceuticals
Common
018119107
10435
1037267
SH
DFND
1
0
1037267
0